chrisvoncsefalvay/vaers-outcomes huggingface dataset:
At first, I thought I had sinusitis, because I am prone to get that. The next day, I thought I might have a head cold. My symptoms included sinus congestion and swelling, difficulty sleeping, and sinus drainage. I took my temperature that day, and it was higher than usual. On 4/14/2023, I took a home antigen test and got a positive result. I immediately went to a walk-in clinic and talked to a PA, who prescribed me molnupiravir and methylprednisolone. When my temperature was taken at the clinic, it was 99.8. I began taking the prescribed medications that day. I then gradually got better, and the methylprednisolone was very helpful. At the time of this writing, I still feel like I'm recovering. I don't feel sick, but I still feel like I have some sinus issues. I'm also sleeping nine or ten hours at night, which is a lot for me. I didn't sleep well during my illness, so I think I'm trying to get caught up on lost sleep.
Double vision, severe headache, frozen left eye, loss in vision in left eye.  Injected on 8/31/2021 on 9/13/2021 experienced symptoms.  Went to ophthalmologist on 9/20/21 and admitted to hospital on 9/27/2021. After 2 MRI's, 2 CT scans, blood work, echocardiogram and spinal tap was diagnosed with Tolosa-Hunt syndrome.  Was told this is a very rare syndrome.
This spontaneous report as received from a other health professional refers to a 15 month old patient of unknown gender. On 30-AUG-2017 the patient was vaccinated with a dose of GARDASIL 9 lot # N018273, expiration date 17-JUN-2019 (route was unknown) for prophylaxis (Product use in unapproved population). No adverse effect reported.
This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second Covid vaccine administered 10 days too early/first Moderna dose received on 19 Dec 2022 and second Moderna dose received on 06 Jan 2023) and NO ADVERSE EVENT (No adverse event) in a 27-year-old male patient who received mRNA-1273 (Spikevax) (batch nos. 015B22A and 015B22A) for COVID-19 prophylaxis.     No known drug allergy.  The patient's past medical history included COVID-19 on 31-Aug-2022.   On 19-Dec-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 06-Jan-2023, received second dose of mRNA-1273 (Spikevax) (Intramuscular) dosage was changed to 1 dosage form. On 06-Jan-2023, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second Covid vaccine administered 10 days too early/first Moderna dose received on 19 Dec 2022 and second Moderna dose received on 06 Jan 2023). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second Covid vaccine administered 10 days too early/first Moderna dose received on 19 Dec 2022 and second Moderna dose received on 06 Jan 2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Aug-2022, SARS-CoV-2 test: Positive.       Patient received second dose of Moderna initial series too early. Instead of doing it at the 1 month or 28 days mark, nurse gave it at the 19th day mark.  Treatment information was not provided.
genital herpes outbreak; This case was reported by a consumer via call center representative and described the occurrence of genital herpes in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included genital herpes (one and half year before reporting date). Previously administered products included Covid vaccine (1st and 2nd shot received on unknown date) and Acyclovir (genital herpes treated with acyclovir).   On 15th August 2021, the patient received the 2nd dose of Shingrix. In August 2021, less than a week after receiving Shingrix, the patient experienced genital herpes. On an unknown date, the outcome of the genital herpes was not recovered/not resolved.   It was unknown if the reporter considered the genital herpes to be related to Shingrix.  Additional details were provided as follows: The case was reported by the patient herself. The age at vaccination was not reported. The patient refused to provide her last name or phone number. The patient received the 2nd dose of Shingrix on sunday and less than a week after the vaccination the patient experienced genital herpes outbreak which was getting worse. The patient did not want an answer any further questions. The reporter did not consent to follow up. The patient did not want an answer any further questions therefore reporter did not ask her MD (doctor of medicine) contact information.
Onset of severe arm pain 10/10 centralized to the anterior  deltoid muscle region. Mild swelling at site.  C/o numbness and tingling at site, muscle spasms, slight weakness of  Right hand grip 4+/5
Patient hospitalized for vaginal delivery of healthy baby. Normal, noncomplicated postpartum course. This was within 6 weeks of receiving COVID vaccination.
Experienced walnut sized mass near injection site. Mass persisted for three days, was painful, and itchy. Mass subsided, but rash and itch remained for more than a week from injection.
Per family pt became more somnolent, gaining weight, jaundiced after 2nd covid vaccine dose.  Pt was admitted to the hospital on 3/23 with decompensated cirrhosis and ecoli bacteremia and died on 3/25.
Got very sick after getting the second dose of Shingrix shot; This case was reported by a consumer via other manufacturer and described the occurrence of sickness in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included influenza, pleurisy, bronchitis and continuous positive airway pressure (Family History) (patient's nephew useed it for unknown breathing condition). Previously administered products included Shingrix (received 1st dose on 28th September 2020) and Fluzone (received on 29th September 2020). Concurrent medical conditions included sciatica. Concomitant products included MMR (MMR vaccine), paracetamol (Tylenol) and vitamins nos (Vitamins).   On 31st December 2020, the patient received the 2nd dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix and an unknown time after receiving MMR vaccine, the patient experienced sickness. On an unknown date, the outcome of the sickness was unknown.   It was unknown if the reporter considered the sickness to be related to Shingrix.  Additional details were provided as follows: The case was reported by patient herself. The patient stated that she had taken Tylenol for the last 5 days (pills at night) and she normally tried not to take this conmed. The patient stated that she got very sick after receiving 2nd dose of shingrix vaccine and she did not have any other adverse events with other vaccines. On 1st March 2021 in morning at 10.30 am, the patient got first dose of Pfizer-Biontech COVID 19 vaccine in left deltoid. The patient was not sure whether Lot number was ENV200 or EN6200 as written on the CDC vaccine record. The patient was fine on the day of vaccination but on next day at around 19 pm, the patient chewing up peanuts and did not know but suddenly she could not breathe and was wheezing for air like her throat was closed off. This happened like 10 times and further 10 breath that she could not get air. The patient knew that there can be air trouble, breathing trouble with COVID, but wanted to ask if this could be a side effect of the Pfizer Biontech vaccine. No other information was reported.
In January 2021 I was hospitalized with COVID-19.  5 doses of Remdesivir. After 1st dose of vaccine I began to notice hair loss.  Huge clumps of hair would fall out. Over about 3 weeks I lost about 90% of my hair.  After this, and after my 2nd dose of the vaccine, I added collagen and protein into my diet and my hair began growing back in June of 2021.  As of today, I have almost grown all of my hair back.
Patient has phobia of needles and had a syncope episode. Vital signs are stable. Ammonia capsule used patient reacted well and recovered fully.
Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Medium, Systemic: Allergic: Itch Generalized-Medium, Systemic: Allergic: Rash Generalized-Medium, Systemic: scabbing over of site-Medium
INCORRECT PRODUCT STORAGE; VACCINE ADMINISTERED AFTER STORAGE OUTSIDE OF RECOMMENDED STORAGE CONDITIONS; This spontaneous report received from a health care professional concerned a 22 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1822809, and expiry: 04-AUG-2022) dose was not reported, administered on 18-JAN-2022 for prophylactic vaccination. Age at time of vaccination 22 years old. No concomitant medications were reported. On 18-JAN-2022, the patient experienced vaccine administered after storage outside of recommended storage conditions. On an unspecified date, the patient experienced incorrect product storage. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the incorrect product storage and vaccine administered after storage outside of recommended storage conditions was not reported. This report was non-serious. This case, from the same reporter is linked to 20220558451, 20220558511, 20220558598, 20220558439 and 20220558638.
Red, swollen arm with itchy rash below injection site, started about 8 days after receiving first dose of vaccine (?covid arm?)
FLULAVAL 0.5 that is given (Lt) deltoid. Noted redness swelling at site of injection and  swelling of hand 11/11/08. 11/12/08 now no swelling of hand, however noted small area of redness at injection site stated put cold compress at site with relief.
"Head hurts really bad". Observed - no breathing difficulty. Mom called, sent back to class at 11.50am. 11.55 - mom called back and her boyfriend will pick student up. 12.55 mom boyfriend picked up, gave inst. on s/s - when to call MD. Later says knee is locking up, on d/c home says leg feels better.
Mild headache, followed by the patient noticing a 1 inch diameter erythemic, mildly sensitive area at site of yellow fever injection, outer aspect left arm.
Injection site swelling; pyrexia; injection site erythema; injection site pain Information has been received from a physician's assistant concerning a patient who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot #650453/0791P). Subsequently the patient developed a fever and injection site swelling, pain and redness. Unspecified medical attention was sought. Subsequently the patient recovered. The reporter expressed a concern about the lot number. No product quality complaint was involved. The records of testing prior to release of this lot have been checked by Quality Assurance and found to be satisfactory. The lot complies with the standards of the Center for Biologics Evaluation and Research and was released. In addition, a review of the Quality Control Quarantine/Rejeciton System revealed that there was no open Quarantine registered against this lot/fill. Additional information has been requested.
HX from father on 9/11/18: patient was fine in the morning was called from school patient had a short 2 min seizure. Temp was 101 at time of seizure, received 4 yr vaccines on 9-10/18. Since seizure patient acting fine.
It woke me up in middle of the night last night; pain/tenderness between injection site and collarbone; pain/tenderness between injection site and collarbone; Swollen lymph nodes; pain/tenderness between injection siteand collarbone that seems to be fromswollen lymph nodes. a light touch hurts, even clothing or even just a blanket rubbing against the area causes pain.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 10Apr2021 10:15 (Lot number: ER8729) at the age of 42 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Infection" (unspecified if ongoing), notes: Patient have a prior history of this issue at the base of my skull that started due to an infection, but was brought on again in 2016 by a medication. This pain/tenderness was exactly the same. The patient's concomitant medications were not reported. Past drug history included: Lamictal, reaction(s): "Tenderness", notes: Pain/tenderness was exactly the same. Lamictal caused this issue previously; Lamictal, reaction(s): "Pain", notes: Pain/tenderness was exactly the same. Lamictal caused this issue previously; lamotrigine (Lamictal), reaction(s): "Drug allergy", notes: Known allergies: Lamictal caused this issue previously. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot Number: EN6207, Administration time: 09:15 , Anatomical location: Left arm), administration date: 20Mar2021, when the patient was 42 years old, for COVID-19 immunisation. The following information was reported: TENDERNESS (non-serious), PAIN (non-serious) all with onset 14Apr2021 01:00, outcome "not recovered" and all described as "pain/tenderness between injection site and collarbone"; LYMPHADENOPATHY (non-serious) with onset 14Apr2021 01:00, outcome "not recovered", described as "Swollen lymph nodes"; LYMPH NODE PAIN (non-serious) with onset 14Apr2021 01:00, outcome "not recovered", described as "pain/tenderness between injection site and collarbone that seems to be from swollen lymph nodes. a light touch hurts, even clothing or even just a blanket rubbing against the area causes pain."; SLEEP DISORDER (non-serious), outcome "not recovered", described as "It woke me up in middle of the night last night". Therapeutic measures were not taken as a result of tenderness, pain, lymphadenopathy, lymph node pain, sleep disorder.  Additional information: Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Patient also experienced a light touch hurts, even clothing (ie, bra strap) or even just a blanket rubbing against the area causes pain.The events did not result in doctor or other healthcare professional office or clinic visit, emergency room or department or urgent care.   No follow-up attempts are needed. No further information is expected.
Began having difficulty ambulating with muscle pain in both hips and lower limbs, but left was more intense usually; worse after being in one position without movement for more than 15 minutes. Started experiencing moods swings - low energy - occasional twinge of having a hard time remembering things. Saw MD and got Steroid dose pack which increased the pain dramatically. Saw numerous bodyworkers attempting to release trigger points, etc. It would feel better for a day, but nothing would hold. Pain slowly increased over the last several months where I cannot walk without severe pain. I am essentially housebound to keep pain manageable and not embarrass myself in public with unexpected screams of pain and occasional bursting into tears. Seeing an acupuncture for treatment and holistic approaches for treatment.
Received vaccine at 1512.  At 1520 began clearing throat; 1530 began frequently clearing her throat and c/o thicken tongue; 1540 continues clearing throat; 1546 given solumendrol 125 mg;   1616  doing fine and left  Took Claritin and Pepcid 20 mg before she came today
Post vax, the pt experienced a fever and abnormal movements with bringing her left arm toward her body, tilting her head to the left, and bringing her left shoulder up to her chin. Possible focal seizure.
Began feeling arm pain and stiffness 2 hours after injection. Lightheadedness, nausea, body aches and elevated temp@ 1500-19:00. Nausea and vomiting from 22:00-04:30.  body aches continued through 10/08
12 hours post-vaccine my heart rate was 115-125 beats per minute for over 5 hours and it was uncontrollable. No sleep, vomiting. The rapid heart rate that was so strong and persistent that it caused my brain to think my body was going to die. I had uncontrollable, racing and intrusive thoughts about the fact that I was about to die and I became incredibly scared and paranoid. I had minor "sleep" paralysis at times where I couldn't move my limbs and they felt incredibly heavy when I attempted to move (sleep in quotation marks because I did not sleep that night).   The intrusive, racing thoughts were spiraling incredibly rapidly - roughly 3 thoughts per second for the entire 5 or so hours that my heart rate was uncontrollable. When attempting to re-direct my thoughts, I was unsuccessful. Scenes/moments from my life flashed before my eyes in shuffle mode (i.e., memories from different parts of my life in no particular order) and at some points there were dark figures/shadows in my imagination that made it seem like I was about to die. My extremities became icy cold as if blood was drained from the areas during this time. I couldn't decide if I would be found dead in my bed or if I should go to the ER. I ultimately stayed home and tried to overcome the side effects (which I did).  Once my heart rate normalized the following morning, the racing and spiraling thoughts lessened, though there is an underlying fear of having these uncontrollable, intrusive, and racing thoughts return at any time.
Eye lids began swelling within 24 hours of vaccine administration.  Next day developed rash on face and neck.  Sought treatment in emergency room.  Treated with Prednisone, Benadryl and Doxycycline per patient report.
Patient was noticed in waiting room  by observers as head-dropping and arms slightly shaking (one observed stated it looked like a possible seizure). Once pharmacist came out to check on patient, he was conscious and responsive, but seemed confused. 911 was called. Patient got up from chair and tried to leave the store. We told him to stay seated. It was apparent that the patient defecated in the chair, so he walked to the bathroom. Pharmacy staff stayed with the patient until EMS arrived on scene. Patient refused to go with EMS.
Patient began to feel "unwell" and was evaluated by Dr.  Vital signs were taken and @ 1050 Dr. gave patient 50mg PO Benadryl.  Patient was observed with improvement noted --then released after symptoms improved and resolved.
rheumatoid arthritis; multiple outbreaks of herpes zoster; This initial spontaneous report was received from a lawyer and a patient of unknown age and gender regarding a case in litigation. The patient's concurrent conditions, medical history, concomitant medications, drug reactions or allergies were not reported. On an unspecified date, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot #, expiration date, route of administration, anatomical location not provided) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). On an unspecified date, soon after receiving zoster vaccine live (ZOSTAVAX), the patient experienced rheumatoid arthritis followed by multiple breaks of herpes zoster. As results of these symptoms, plaintiff was seen and treated by medical providers and was still under their care. As a directed and proximate result, the patient sustained severe and permanent personal injuries. Further, Patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. At the reporting time, the outcome of rheumatoid arthritis and herpes zoster were considered as not recovered.   The reporters considered rheumatoid arthritis and herpes zoster to be related to Zoster Vaccine Live (ZOSTAVAX).     The reporters considered both events to be disabling. Upon internal review rheumatoid arthritis was determined to be a medically significant event.
Dizziness, Palpitations & HYPERtension Narrative: BP normally runs in the 120's and is now 179/105 Palpitations come and go After 2nd dose she went to ER and had an EKG took Benedryl for 2weeks after 1st dose
C/o fever 101 w/sl tenderness @ inject site; fever became progressively higher; fluid detected in lungs; admitted & released p/ 3 days; dx uncertain;
Started having bright red blood in stool daily around January 2022. After 2 colonoscopies, was diagnosed with IBD in Nov 2022.
the patient may have had a seizure; Immediately after receiving these vaccinations, the patient fainted; This spontaneous report was received from a registered nurse via a company representative and refers to a female patient of unknown age. The patient's pertinent medical history, drug reactions, allergies and concomitant therapies were unknown. On an unknown date in approximately July 2019 (reported as about 3 months ago), the patient received a dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, intramuscularly (exact dose, dose number, anatomical location, lot # and expiration date were not reported) for routine vaccination (prophylaxis), a dose of diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid (manufacturer unknown) (formulation, exact dose, dose number, route of administration, anatomical location, indication, lot # and expiration date were not reported) and a dose of meningococcal vaccine (unspecified, reported as meningitis vaccine)(manufacturer unknown) (formulation, exact dose, dose number, route of administration, anatomical location, indication, lot # and expiration date were not reported). On that same day, immediately after receiving these vaccinations, the patient fainted and might had a seizure. The patient did not receive any treatment for the events and it was unknown if she had any lab diagnostics or studies performed. It was stated that within few minutes after she fainted, the patient completely recovered from the events. The causality assessment was not provided.    Upon internal review, the events of the patient fainted and had a seizure were determined to be medically significant.
Fifteen minutes post vaccination pt. developed rash on wrist and felt "weird". Three minutes later pt. developed cough and rash that spread to face, trunk and extremities. BP 149/81, and pt. reported abnormal for her. FNP gave 50 mg IM Benadryl and EMS dispatched. Pt. was transported to Hospital via EMS for evaluation.
6 month old patient receiving 1st dose of Pfizer covid vaccine. Within 15 minutes of required waiting time, pt experienced slight redness around eye area.  No other visible symptoms.  No breathing issues. No other adverse reaction.  Pt stayed for another few minutes and I followed up with pt's mother when they arrived at home. Pt's mother reported that redness was clearing and no other adverse reactions noted.
Pt was provided with a booster dose of monovalent Pfizer rather than the recommended bivalent product.  Pt not immunocompromised.  No side effects or adverse events occurred.
eye burning; ear burning; This is a spontaneous report from a contactable consumer (Patient). A 23-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), Solution for injection, via an unspecified route of administration, administered in Arm Left on 31Aug2021 10:00 (at the age of 23-year-old) as unknown single dose for covid-19 immunisation. Medical history was reported as none. Concomitant medications were not reported. No additional vaccines was administered on same date of the Pfizer suspect. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. AE following prior vaccinations was reported as none. On 31Aug2021. the patient experienced eye burning and ear burning. Patient did not visit to emergency Room or physician office due to adverse event. No test was performed. The outcome of events was not recovered.   Follow-up attempts are completed. No further information is expected.